ImmunOs Therapeutics Company

ImmunOs Therapeutics AG is a biotechnology company that is currently in the clinical stage. They specialize in discovering and developing new human immunomodulatory proteins that play a role in both innate and adaptive immunity. Their goal is to create novel therapeutics that will help improve the lives of patients who suffer from serious diseases.

Headquarters: Zurich
Employee Number: 11-50
Founded Date: 2014
Industry: PharmTech
Estimated Revenue: US$ 195.4 Billion